Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

Introduction: Praziquantel (PZQ) is the only commercially available drug for schistosomiasis. The current shortage of alternative effective drugs and the lack of successful preventive measures enhance its value. The increase in the prevalence of PZQ resistance under sustained drug pressure is, ther...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomédica
Asıl Yazarlar: Eglal I. Amer, Iman F. Abou-El-Naga, Laila M. Boulos, Heba S. Ramadan, Salwa S. Younis
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Instituto Nacional de Salud 2022
Konular:
Medicina
liposomes
praziquantel
drug resistance
Schistosoma mansoni
Online Erişim:https://www.redalyc.org/articulo.oa?id=84371265007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller